(NYSE: NVST) Envista Holdings's forecast annual revenue growth rate of 3.08% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.54%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.65%.
Envista Holdings's revenue in 2025 is $2,552,900,000.On average, 7 Wall Street analysts forecast NVST's revenue for 2025 to be $433,779,490,628, with the lowest NVST revenue forecast at $423,115,277,292, and the highest NVST revenue forecast at $438,011,806,673. On average, 7 Wall Street analysts forecast NVST's revenue for 2026 to be $447,863,723,761, with the lowest NVST revenue forecast at $436,443,051,236, and the highest NVST revenue forecast at $456,999,730,000.
In 2027, NVST is forecast to generate $465,392,737,769 in revenue, with the lowest revenue forecast at $452,614,194,409 and the highest revenue forecast at $474,349,101,568.